Pharma

API (Active Pharmaceutical Ingredients) is an important part of ORIENTOXIN-BIOTECH’s core business. ORIENTIXON BIOTECH has developed a number of APIs from various snake venoms, belonging to the therapeutic fields of anticoagulants, analgesia, homeostasis, antifibrinolytics, and others.

ORIENTOXIN BIOTECH has developed a number of APIs from various snake venoms, belonging to the therapeutic fields of anticoagulants, analgesia, homeostasis, antifibrinolytics, and others.

We have successfully registered two APIs (Defibrase and Cobratide) with SFDA for anticoagulants and analgesia.

Our antivirus candidate, modified cobrotoxin, shows proven results for HIV in Pre-clinical trials. We are filing for Phase 1 clinical trials application.

We are also doing pre-clinical of Nerve Growth Factor (NGF) and Cobra Venom Factor (CVF). NGF shows therapeutic effect for nerves regression diseases such as Alzheimer disease. CVF can be applied to reduce hyperacute rejection in organ transplantation operations.

Another protein that has been widly studied is Cytotoxin. A number of researchers and scientists have conducted extensive study of Cytotoxin for its antitumor potential. We are willing to establish collaborations with research institutes, companies or universities in these three directions.

We offer the biopharmaceutical industry outstanding quality products conforming to cGMP, as well as a full range of services to ensure full customer satisfaction. We secure the absolute competition advantage in purity and activity through the qualitative materials that we have and the perfect Quality Control system in our manufacturing process.

^TOP^